MedPath

Susceptibility of Cardiorespiratory Responses to Ozone During Cycling Exercise

Not Applicable
Completed
Conditions
Ozone Exposure During Rest and Exercise
Registration Number
NCT05473000
Lead Sponsor
University of British Columbia
Brief Summary

Ground level ozone (O3) is a common airborne pollutant that is well recognized to cause negative respiratory symptoms and impair pulmonary function. The proposed study aims to have participants perform submaximal and maximal cycling exercise protocols exposed to both O3 and room air in a crossover design to evaluate how ventilatory patterns, pulmonary function, development of symptoms, and cycling performance are impacted by O3 exposure. Additionally, the investigators look to compare responses between O3 at rest and during exercise to predict which subjects may be most susceptible to adverse response, as considerable interindividual variability exists.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Male
Target Recruitment
20
Inclusion Criteria
  • Healthy males between the age of 18 and 50
  • Currently training and/or competing in endurance sport
  • VO2max >60 ml/kg/min
  • Able to communicate sufficiently using the English language
Exclusion Criteria
  • History of smoking
  • Upper respiratory tract infection within the last 4 weeks
  • Presence of any chronic respiratory disease

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Primary Outcome Measures
NameTimeMethod
Time-to-exhaustion on Maximal Cycling BoutFrom the beginning of the maximal constant work-rate cycling bout until volitional exhaustion occurs (roughly 1-5 minutes)

Measurement of time (in seconds) to volitional exhaustion on a constant work-rate cycling trial at 110% of previously determined maximal power output.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

University of British Columbia

🇨🇦

Vancouver, British Columbia, Canada

University of British Columbia
🇨🇦Vancouver, British Columbia, Canada

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.